Drugs Made In America Acquisition II Secures $150,000 Convertible Bridge Note From Alpha Multi Family Office

About this update from Drugs Made In America Acquisition Ii Corp.

Drugs Made In America Acquisition II entered into an unsecured convertible bridge note to support near-term transaction costs. The $150,000 note bears no interest, matures in nine months, and may convert at the investor’s option into shares of the post-combination company at a 35% discount upon completion of the business combination. Proceeds will fund accounting, audit and other combination-related expenses. The bridge note is the first tranche toward a contemplated $1.4 million convertible notes financing under a letter of intent.Agreement details:Agreement type: Unsecured zero-interest convertible bridge promissory noteCounterparty: Alpha Multi Family OfficeSigned / Effective: Mar 11 2026 / sameDuration / Termination: 9 monthsReason: Fund accounting, audit and other business combination expensesOriginal SEC Filing: This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

View stock analysis, news, and events for Drugs Made In America Acquisition Ii Corp.